Bio-Rad Labs (BIO) Tops Q1 EPS by 28c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Nasdaq ticks up as tech stocks steady; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $365.22 +0.47%
EPS Growth %: -1.3%
Financial Fact:
Net sales: 516.78M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
EPS Growth %: -1.3%
Financial Fact:
Net sales: 516.78M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q1 EPS of $0.61, $0.28 better than the analyst estimate of $0.33. Revenue for the quarter came in at $472.8 million versus the consensus estimate of $474.6 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AI-powered cyber threats light a fire under cybersecurity stocks
- SS&C Technologies shares fall on weak Q4 revenue outlook
- Goldman Sachs sees US stocks dip on tech earnings and macro shifts
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
